Antipsychotics in the treatment of delirium in older hospitalized adults: A systematic review

Journal of the American Geriatrics Society

Volumn 59, Issue SUPPL. 2, 2011, Pages

  Flaherty, Joseph H ^a,b   Gonzales, Jeffrey P ^c   Dong, Birong ^d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^d SICHUAN UNIVERSITY   (China)

Author keywords

antipsychotics; delirium; elderly; hospitalized

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; MIANSERIN; NEUROLEPTIC AGENT; OLANZAPINE; PEROSPIRONE; PLACEBO; QUETIAPINE; RISPERIDONE;

DELIRIUM; DISEASE SEVERITY; HOSPITALIZATION; HUMAN; PATIENT REFERRAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

AGED; ANTIPSYCHOTIC AGENTS; DELIRIUM; HOSPITALIZATION; HUMANS;

EID: 81555220925     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03675.x     Document Type: Review

References (49)

1. American Psychiatric Association. Practice guidelines for the treatment of patients with delirium. Am J Psychiatry 1999; 156: 1-20.
2. Sharon KI, Fearing MA, Marcantonio RA,. "Chapter 53. Delirium" (Chapter). In:, Halter JB, Ouslander JG, Tinetti ME, Studenski S, High KP, Asthana S,., eds. 6th Ed. Hazzard's Geriatric Medicine and Gerontology. Available at. Accessed March 19, 2011.
3. Hshieh TT, Fong TG, Marcantonio ER, et al. Cholinergic deficiency hypothesis in delirium: A synthesis of current evidence. J Gerontol A Biol Sci Med Sci 2008; 63A: 764-772.
4. Trzepacz PT,. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000; 5: 132-148.
5. Carnes M, Howell T, Rosenberg M, et al. Physicians vary in approaches to the clinical management of delirium. J Am Geriatr Soc 2003; 51: 234-239. (Pubitemid 36205853)
6. Meagher DJ,. Impact of an educational workshop upon attitudes towards pharmacotherapy for delirium. Int Psychogeriatr 2010; 22: 938-946.
7. Tropea J, Slee J, Holmes AC, et al. Use of antipsychotic medications for the management of delirium: An audit of current practice in the acute care setting. Int Psychogeriatr 2009; 21: 172-179.
8. Briskman I, Dubinski R, Barak Y,. Treating delirium in a general hospital: A descriptive study of prescribing patterns and outcomes. Int Psychogeriatr 2010; 22: 328-331.
9. Meagher D,. Motor subtypes of delirium: Past, present and future. Int Rev Psychiatry 2009; 21: 59-73.
10. Platt MM, Breitbart W, Smith M, et al. Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci 1994; 6: 66-67.
11. Nguyen ML, Patel SB, Shapiro MA,. Scheduled low-dose risperidone for agitation in elderly patients. Ann Longterm Care 2011; 19: 40-43.
12. National Institute for Health and Clinical Excellence. Delirium: Diagnosis, Prevention and Management. 2010 [on-line]. Available at Accessed March 23, 2011.
13. Clinical Epidemiology and Health Service Evaluation Unit, Melbourne Health and the Australian Health Ministers' Health Care of Older Australians Standing Committee. Clinical Practice Guidelines for the Management of Delirium in Older People. October 2006 [on-line]. Available at Accessed March 23, 2011.
14. Francis J,. Delirium in older patients. J Am Geriatr Soc 1992; 40: 829-838.
15. Gill SS, Bronskill SE, Normand SL, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007; 146: 775-786. (Pubitemid 351650498)
16. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed. Washington, DC: American Psychiatric Association, 1980.
17. Schulz KF, Altman DG, Moher D,; CONSORT Group. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010; 1: 152.
18. Mulrow CD, Oxman AD,. Cochrane Collaboration Handbook. Oxford, UK: Oxford Update Software, 1997.
19. Fick DM, Agostini JV, Inouye SK,. Delirium superimposed on dementia: A systematic review. J Am Geriatr Soc 2002; 50: 1723-1732. (Pubitemid 35192547)
20. Martin NH, Stones MJ, Young JE, et al. Development of delirium: A prospective cohort study in a community hospital. Int Psychogeriatr 2000; 12: 117-127. (Pubitemid 30180719)
21. Levkoff SE, Evans DA, Liptzin B, et al. Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med 1992; 152: 334-340.
22. Trzepacz PT, Baker RW, Greenhouse J,. A symptom rating scale for delirium. Psychiatry Res 1988; 23: 89-97. (Pubitemid 18038426)
23. Breitbart W, Rosenfeld B, Roth A, et al. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997; 13: 128-137. (Pubitemid 27172870)
24. Trzepacz PT, Mittal D, Torres R, et al. Validation of the Delirium Rating Scale-revised-98: Comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 2001; 13: 229-242. (Pubitemid 32499675)
25. Breitbart W, Tremblay A, Gibson C,. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002; 43: 175-182. (Pubitemid 34522527)
26. Parellada E, Baeza I, de Pablo J, et al. Risperidone in the treatment of patients with delirium. J Clin Psychiatry 2004; 65: 348-353.
27. Sasaki Y, Matsuyama T, Inoue S, et al. A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry 2003; 64: 1316-1321. (Pubitemid 37490236)
28. Kim KY, Bader GM, Kotlyar V, et al. Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 2003; 16: 29-31. (Pubitemid 37408287)
29. Takeuchi T, Furuta K, Hirasawa T,. Perospirone in the treatment of patients with delirium. Psychiatry Clin Neurosci 2007; 61: 67-70. (Pubitemid 46089408)
30. Nakamura J, Uchimura N, Yamada S, et al. Does plasma free-3-methoxy-4- hydroxyphenyl(ethylene)glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium. Int Clin Psychopharmacol 1997; 12: 147-152. (Pubitemid 27283323)
31. Han CS, Kim YK,. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004; 45: 297-301.
32. Kim JY, Jung IK, Han C, et al. Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. Psychiatry Clin Neurosci 2005; 59: 183-188. (Pubitemid 40524954)
33. Lee KU, Won WY, Lee HK, et al. Amisulpride versus quetiapine for the treatment of delirium: A randomized, open prospective study. Int Clin Psychopharmacol 2005; 20: 311-314.
34. Kim SW, Yoo JA, Lee SY, et al. Risperidone versus olanzapine for the treatment of delirium. Hum Psychopharmacol 2010; 25: 298-302.
35. Tahir TA, Eeles E, Karapareddy V, et al. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res 2010; 69: 485-490.
36. Pae CU, Lee SJ, Lee CU, et al. A pilot trial of quetiapine for the treatment of patients with delirium. Hum Psychopharmacol 2004; 19: 125-127.
37. Hu H, Deng W, Yang H,. A prospective random control study comparison of olanzapine and haloperidol in senile delirium. Chongqing Med J 2004; 8: 1234-1237.
38. Seitz DP, Gill SS, van Zyl LT,. Antipsychotics in the treatment of delirium: A systematic review. J Clin Psychiatry 2007; 68: 11-21. (Pubitemid 46220119)
39. Lonergan E, Britton AM, Luxenberg J, Wyller T,. Antipsychotics for delirium. Cochrane Database Syst Rev 2007; April 18: CD005594.
40. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, DC: American Psychiatric Association, 1994.
41. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed., Revised. Washington, DC: American Psychiatric Association, 1987.
42. Rudberg MA, Pompei P, Foreman MD, et al. The natural history of delirium in older hospitalized patients: A syndrome of heterogeneity. Age Ageing 1997; 26: 169-174. (Pubitemid 27290383)
43. Rockwood K,. The occurrence and duration of symptoms in elderly patients with delirium. J Gerontol 1993; 48: M162-M166. (Pubitemid 23199259)
44. Lundstrom M, Edlund A, Karlsson S, et al. A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. J Am Geriatr Soc 2005; 53: 622-628. (Pubitemid 41623484)
45. Milisen K, Foreman MD, Abraham IL,. A nurse-led interdisciplinary intervention program for delirium in elderly hip-fracture patients. J Am Geriatr Soc 2001; 49: 523-532. (Pubitemid 32525021)
46. Young J, Inouye SK,. Delirium in older people. BMJ 2007; 334: 842-846. (Pubitemid 46706931)
47. Inouye SK, Charpentier PA,. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996; 275: 852-857. (Pubitemid 26087222)
48. Maldonado JR,. Pathoetiological model of delirium: A comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment. Crit Care Clin 2008; 24: 789-856.
49. Heres S, Davis J, Maino K, et al. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: An exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry 2006; 163: 185-194. (Pubitemid 44480836)